Tech Company Financing Transactions
Valerion Therapeutics Funding Round
Valerion Therapeutics secured a funding round on 10/1/2024. Investors included Hest Investments.
Transaction Overview
Company Name
Announced On
10/1/2024
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to conduct further testing and development of its electric vehicles (EVs) and all battery-operated technology.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
100 Main St. 110
Concord, MA 01742
USA
Concord, MA 01742
USA
Phone
Website
Email Address
Not Recorded
Overview
Valerion Therapeutics is utilizing a proprietary antibody-mediated delivery platform to target therapies to specific tissues via a well-known and broadly studied transport pathway.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Deborah Ramsdell
Chief Medical Officer
Hal Landy
Chief Scientific Officer
Dustin Armstrong
Browse more venture capital transactions:
Prev: 10/1/2024: Enlaye venture capital transaction
Next: 10/1/2024: xtype venture capital transaction
Share this article
Where The Data Comes From
We do our best to record tech company VC transactions. VC transactions reported here are derived from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs